Jiang Ming T, Nakae Yuri, Ljubkovic Marko, Kwok Wai-Meng, Stowe David F, Bosnjak Zeljko J
Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Anesth Analg. 2007 Oct;105(4):926-32, table of contents. doi: 10.1213/01.ane.0000278640.81206.92.
Activation of the mitochondrial adenosine triphosphate (ATP)-sensitive K+ channel (mitoK(ATP)) has been proposed as a critical step in myocardial protection by isoflurane-induced preconditioning in humans and animals. Recent evidence suggests that reactive oxygen species (ROS) may mediate isoflurane-mediated myocardial protection. In this study, we examined the direct effect of isoflurane and ROS on human cardiac mitoK(ATP) channels reconstituted into the lipid bilayers.
Inner mitochondrial membranes were isolated from explanted human left ventricles not suitable for heart transplantation and fused into lipid bilayers in symmetrical potassium glutamate solution (150 mM). ATP-sensitive K+ currents were recorded before and after exposure to isoflurane and H2O2 under voltage clamp.
The human mitoK(ATP) was identified by its sensitivity to inhibition by ATP and 5-hydroxydecanoate. Addition of isoflurane (0.8 mM) increased the open probability of the mitoK(ATP) channels, either in the presence or absence of ATP inhibition (0.5 mM). The isoflurane-mediated increase in K+ currents was completely inhibited by 5-hydroxydecanoate. Similarly, H2O2 (200 microM) was able to activate the mitoK(ATP) previously inhibited by ATP.
These data confirm that isoflurane, as well as ROS, directly activates reconstituted human cardiac mitoK(ATP) channel in vitro, without apparent involvement of cytosolic protein kinases, as commonly proposed. Activation of the mitoK(ATP) channel may contribute to the myocardial protective effect of isoflurane in the human heart.
线粒体三磷酸腺苷(ATP)敏感性钾通道(mitoK(ATP))的激活被认为是异氟烷诱导的人类和动物心肌预处理中发挥心肌保护作用的关键步骤。最近的证据表明,活性氧(ROS)可能介导异氟烷介导的心肌保护作用。在本研究中,我们检测了异氟烷和ROS对重构于脂质双分子层中的人类心脏mitoK(ATP)通道的直接作用。
从不适合心脏移植的离体人类左心室中分离出线粒体内膜,并在对称的谷氨酸钾溶液(150 mM)中融合到脂质双分子层中。在电压钳制下,记录暴露于异氟烷和过氧化氢前后的ATP敏感性钾电流。
通过其对ATP和5-羟基癸酸抑制的敏感性鉴定了人类mitoK(ATP)。添加异氟烷(0.8 mM)可增加mitoK(ATP)通道的开放概率,无论是否存在ATP抑制(0.5 mM)。异氟烷介导的钾电流增加被5-羟基癸酸完全抑制。同样,过氧化氢(200 microM)能够激活先前被ATP抑制的mitoK(ATP)。
这些数据证实,异氟烷以及ROS在体外可直接激活重构的人类心脏mitoK(ATP)通道,而不像通常所认为的那样明显涉及胞质蛋白激酶。mitoK(ATP)通道的激活可能有助于异氟烷对人类心脏的心肌保护作用。